Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award

Dr. Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award 

Researcher at BioFront | South Korea

Dr. Sun Jong Kim is a highly accomplished biotechnology and life sciences professional whose career reflects sustained contributions to in vitro diagnostics, stem cell science, biomolecular research, and translational biomedical innovation. Equipped with a strong academic foundation including bachelor’s, master’s, and doctoral studies in life sciences, Dr. Sun Jong Kim has developed deep expertise in cellular biology, developmental biology, and molecular mechanisms of pluripotency. His professional journey includes senior research and leadership roles across multiple biomedical organizations, where he has guided R&D programs involving the establishment and maintenance of pluripotent stem cell lines, large-scale microalgae production systems, medical device development, and regulatory preparation for diagnostic technologies. He has contributed to the development of human embryonic stem cell resources, in vitro differentiation platforms, and advanced diagnostic systems applied to areas such as oncology, COVID-19 rapid testing, and point-of-care technologies. His industrial leadership also includes oversight of product development pipelines, quality assurance systems, and multidisciplinary research operations, demonstrating an ability to translate scientific results into usable biomedical solutions that directly support clinical and research infrastructures. His research outputs include numerous scientific publications, national and international presentations, and patents in areas such as stem cell culturing techniques, photobioreactors, and biomaterial-based innovations. The measurable impact of his scholarly contribution is represented by 24 citations by 24 documents, 2 indexed documents, and an h-index of 2, reflecting ongoing engagement and recognition within the scientific community. Dr. Sun Jong Kim’s research interests encompass stem cell biology, human cell culture systems, the regulation of self-renewal and differentiation pathways, bioprocess design, clinical diagnostics, and biotechnology commercialization. His work has been supported by significant research grants and has contributed to advancements in both academic discovery and applied biomedical engineering. In addition to laboratory research, he has played a crucial role in the development, certification, and evaluation of diagnostic medical devices aligned with international regulatory standards and real-world clinical needs. Through his ongoing work at Biofront and other institutions, Dr. Sun Jong Kim continues to drive innovation in science and technology, contributing to advancements that support more accurate diagnostics, greater understanding of biological systems, and the modernization of biomedical tools used in healthcare and life science research.

Profile: Scopus

Featured Publications:

Kim, S. J.,(1999). Isolation of developmentally regulated novel genes based on sequence identity and gene expression patterns. Molecules and Cells, 9, 207–218.

Kim, S. J.,(2001). Ovarian expression of melatonin Mel(1) receptor mRNA during mouse development. Molecular Reproduction and Development, 59, 126–132.

Kim, S. J.,(2003). Isolation and culture of human embryonic stem-like cells from abnormal blastocysts. Korean Journal of Fertility and Sterility, 30, 293–301.

Kim, S. J.,(2003). Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biology of Reproduction, 69, 2007–2014.

Kim, S. J.,(2004). Establishment of embryonic germ cells from cultured human primordial germ cells and their differentiation into neuronal cells. Molecules and Cells, 17, 309–315.

Kim, S. J.,(2004). Recent advances in human embryonic stem cell research. Journal of the Korean Medical Association, 918–925.

Kim, S. J.,(2004). Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. Stem Cells, 22, 950–961.

Kim, S. J.,(2004). Available human feeder cells for the maintenance of human embryonic stem cells. Reproduction, 128, 727–735.

Tom Schimanski | Medicine and Dentistry | Best Researcher Award

Mr. Tom Schimanski | Medicine and Dentistry | Best Researcher Award  

Student at Universität Regensburg | Germany

Mr. Tom Schimanski is an emerging researcher at Universität Regensburg whose work bridges the intersection of medicine, surgery and biomedical innovation. His academic background reflects an early commitment to scientific rigor and medical advancement, culminating in advanced studies and a doctoral research focus within the Department of Plastic, Hand, and Reconstructive Surgery. Building upon a foundation of clinical training, he has developed extensive expertise in translational medicine, integrating laboratory research with real-world surgical applications. His scholarly engagement is marked by active participation in experimental studies addressing tissue regeneration, cellular responses, and cryopreservation methodologies for adipose and connective tissues. Mr. Tom Schimanski’s contributions to the scientific community are evident through his publications in internationally indexed journals such as Cells, where his research explores mechanisms of ferroptosis, biocompatibility of anesthetics, exosome mediated cellular communication, and innovative imaging approaches like multispectral optoacoustic tomography. With 3 published documents, 1 citation, and an h-index of 1, he exemplifies the diligence and precision of a young scientist dedicated to building a lasting impact in medical science. His ongoing collaborations with institutions such as Helmholtz Zentrum München further strengthen his multidisciplinary approach, combining cellular biology, materials science, and reconstructive medicine. Mr. Tom Schimanski’s research interests encompass tissue engineering, regenerative medicine, biomaterials development, and translational surgery, focusing on developing clinically viable strategies to enhance wound healing and graft preservation. His work also reflects a broader vision for integrating biotechnological innovations into surgical practice, fostering advancements that align patient safety with scientific discovery. Through his deep engagement in both experimental and clinical contexts, he continues to advance methodologies that could redefine regenerative outcomes and improve the sustainability of reconstructive procedures. With a growing research record and a strong foundation in evidence-based medicine, Mr. Tom Schimanski represents a new generation of clinician-scientists whose contributions are shaping the evolving landscape of biomedical research and surgical innovation. His pursuit of excellence underscores a commitment to translating science into tangible medical progress, marking him as a promising and impactful figure in contemporary medical research.

Profile: Scopus | Orcid

Featured Publications:

Schimanski, T., Loucas, R., Loucas, M., Brébant, V., Anker, A., Klein, S., Diesch, S. T., Pagani, A., & Prantl, L. (2025). Histological and immunohistochemical characteristics of mechanically processed adipose tissue A systematic review and meta-analysis. Cells, 14(21), 1664.

Schimanski, T., Prantl, L., Eigenberger, A., Felthaus, O., Loucas, R., Utpatel, K., & Steer, K. (2025). CELTPLUS fat increases the metabolic activity as well as the SVF-yield significantly when compared to CELT fat, even after cryopreservation with DMSO. Cells, 14(16), 1270.

Schimanski, T., Loucas, R., Loucas, M., Felthaus, O., Brébant, V., Klein, S., Anker, A., Frank, K., Siegmund, A., Pagani, A., & Prantl, L. (2025). Histology and immunohistochemistry of adipose tissue: A scoping review on staining methods and their informative value. Cells, 14(12), 898.

Eigenberger, A., Felthaus, O., Bartsch, A., Schimanski, T., Utpatel, K., & Prantl, L. (2025). The influence of sedimentation on the composition of the lipoaspirate and the effects on further mechanical processing. Cells, 14(8), 601.